Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Ferone

Showing results (81-90 of 134) with videos related to

Pageof 14
Sort By:
Journal of Endocrinological Investigation|May 28, 2017
Anti-tumoral effects of somatostatin analogs: a lesson from the CLARINET studyM Albertelli, E Nazzari, S Sciallero, et al.
Hormone Research|January 1, 1993
Effects of a chronic treatment with octreotide in patients with functionless pituitary adenomasB Merola, A Colao, D Ferone, et al.
The Journal of Clinical Endocrinology and Metabolism|November 14, 1998
Orbital scintigraphy with [111In-diethylenetriamine pentaacetic acid-D-phe1]-octreotide predicts the clinical response to corticosteroid therapy in patients with Graves' ophthalmopathyA Colao, S Lastoria, D Ferone, et al.
The Journal of Clinical Endocrinology and Metabolism|June 17, 1998
Reversibility of joint thickening in acromegalic patients: an ultrasonography studyA Colao, P Marzullo, G Vallone, et al.
Journal of Endocrinological Investigation|July 2, 1998
Effect of surgery and radiotherapy on visual and endocrine function in nonfunctioning pituitary adenomasA Colao, G Cerbone, P Cappabianca, et al.
Clinical Endocrinology|August 1, 1996
Vasopressin levels in Cushing's disease: inferior petrosal sinus assay, response to corticotrophin-releasing hormone and comparison with patients without Cushing's diseaseA Colao, D Ferone, A Di Sarno, et al.
Neuroendocrinology|November 1, 1996
Tumor necrosis factor-alpha increases after corticotropin-releasing hormone administration in Cushing's disease. In vivo and in vitro studiesB Merola, S Longobardi, A Colao, et al.
Journal of Endocrinological Investigation|April 22, 2006
Potential indications for somatostatin analogues: immune system and limphoproliferative disordersD Ferone, E Resmini, M Boschetti, et al.
Hormone Research|July 1, 1996
Corticotropin-releasing hormone administration increases alpha-melanocyte-stimulating hormone levels in the inferior petrosal sinuses in a subset of patients with Cushing's diseaseA Colao, B Merola, A Di Sarno, et al.
Journal of Endocrinological Investigation|March 28, 2023
Impact of microscopic extrathyroidal extension on differentiated thyroid cancer post-surgical risk of recurrence: a retrospective analysisL Patti, S Gay, L Musso, et al.
Pageof 14

Showing results (81-90 of 134) with videos related to

Sort By:
Pageof 14
Journal of Endocrinological Investigation|May 28, 2017
Anti-tumoral effects of somatostatin analogs: a lesson from the CLARINET studyM Albertelli, E Nazzari, S Sciallero, et al.
Hormone Research|January 1, 1993
Effects of a chronic treatment with octreotide in patients with functionless pituitary adenomasB Merola, A Colao, D Ferone, et al.
The Journal of Clinical Endocrinology and Metabolism|November 14, 1998
Orbital scintigraphy with [111In-diethylenetriamine pentaacetic acid-D-phe1]-octreotide predicts the clinical response to corticosteroid therapy in patients with Graves' ophthalmopathyA Colao, S Lastoria, D Ferone, et al.
The Journal of Clinical Endocrinology and Metabolism|June 17, 1998
Reversibility of joint thickening in acromegalic patients: an ultrasonography studyA Colao, P Marzullo, G Vallone, et al.
Journal of Endocrinological Investigation|July 2, 1998
Effect of surgery and radiotherapy on visual and endocrine function in nonfunctioning pituitary adenomasA Colao, G Cerbone, P Cappabianca, et al.
Clinical Endocrinology|August 1, 1996
Vasopressin levels in Cushing's disease: inferior petrosal sinus assay, response to corticotrophin-releasing hormone and comparison with patients without Cushing's diseaseA Colao, D Ferone, A Di Sarno, et al.
Neuroendocrinology|November 1, 1996
Tumor necrosis factor-alpha increases after corticotropin-releasing hormone administration in Cushing's disease. In vivo and in vitro studiesB Merola, S Longobardi, A Colao, et al.
Journal of Endocrinological Investigation|April 22, 2006
Potential indications for somatostatin analogues: immune system and limphoproliferative disordersD Ferone, E Resmini, M Boschetti, et al.
Hormone Research|July 1, 1996
Corticotropin-releasing hormone administration increases alpha-melanocyte-stimulating hormone levels in the inferior petrosal sinuses in a subset of patients with Cushing's diseaseA Colao, B Merola, A Di Sarno, et al.
Journal of Endocrinological Investigation|March 28, 2023
Impact of microscopic extrathyroidal extension on differentiated thyroid cancer post-surgical risk of recurrence: a retrospective analysisL Patti, S Gay, L Musso, et al.
Pageof 14